Epigenetic Subtypes of High-Grade T1 Bladder Cancer Reveal Intra-Tumor Heterogeneity and Distinct Interactions with Tumor Microenvironment
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 41 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Bladder cancerThis series is part of our curated briefing on it.
- Samples
- 41 samples: 26 distinct titles, 2 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironmentTheranostics · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281743_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1185647 and SRA study SRP544911. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 41 sample titles: 26 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8627428 MP1
- GSM8627429 MP3
- GSM8627430 MP5
- GSM8627431 MP6
- GSM8627432 MP8
- GSM8627433 MP9
- GSM8627434 MP1, input
- GSM8627435 MP3, input
- GSM8627436 MP5, input
- GSM8627437 MP6, input
- GSM8627438 MP8, input
- GSM8627439 MP9, input
- GSM8627440 ucc10
- GSM8627441 ucc11
- GSM8627442 ucc1
- GSM8627443 ucc12
- GSM8627444 ucc, input
- GSM8627445 ucc13
- GSM8627446 ucc3
- GSM8627447 ucc4
- GSM8627448 ucc5
- GSM8627449 ucc7
- GSM8627450 ucc8
- GSM8627451 ucc9
- GSM8627452 ucc3, input
- GSM8627453 ucc4, input
- GSM8627454 ucc5, input
- GSM8627455 ucc7, input
- GSM8627456 ucc8, input
- GSM8627457 pooledinput
- GSM9511067 MPBC1_sample
- GSM9511068 MPBC2_sample
- GSM9511069 vh122sample
- GSM9511070 vh125sample
- GSM9511071 vh12sample
- GSM9511072 vh15sample
- GSM9511073 vh176sample
- GSM9511074 vh1sample
- GSM9511075 vh24sample
- GSM9511076 vh61sample
+ 1 more — browse all 41 samples with per-sample file links →
- GSE176493 Comprehensive target engagement by EZH2 inhibitor CPI-0209 allows for preferential targeting of ARID1A mutant urothelial carcinoma 252 samples same disease briefing
- GSE181389 Transcriptome profiling of HOXA13 and HOXB13 expression knockdown in bladder cancer cell lines. 59 samples same disease briefing
- GSE149652 Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer 28 samples same disease briefing
- GSE171024 Potential Roles of IGF2BP3 in Bladder Cancer 12 samples same disease briefing
- GSE193755 Human bladder cancer cell line high throughput sequencing - genes regulated by hMSH2 12 samples same disease briefing
- GSE214886 Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer 12 samples same disease briefing
- GSE211924 UCHL5 promotes Tumorigenesis of Bladder Cancer by Activating AKT/mTOR signaling pathway and targeting c-myc, SLC25A19, and ICAM5. 9 samples same disease briefing
- GSE172359 Combination of urine exosomal mRNAs and lncRNAs as novel diagnostic biomarkers for bladder cancer 6 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.